BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6335633)

  • 1. [What can be expected of biological tests in scleroderma?].
    Meyer O
    Ann Med Interne (Paris); 1984; 135(8):584-90. PubMed ID: 6335633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antinuclear antibodies, complement and circulating immune complexes in scleroderma].
    Cárdenas Ortega A; Mejía Arregui S; Orozco Medina H; Arroyave CM
    Alergia; 1981 Jul; 28(3):111-20. PubMed ID: 7036785
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticentromere antibodies--clinical correlates.
    Wade JP; Sack B; Schur PH
    J Rheumatol; 1988 Dec; 15(12):1759-63. PubMed ID: 3265957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma.
    Schnitz W; Taylor-Albert E; Targoff IN; Reichlin M; Scofield RH
    J Rheumatol; 1996 Oct; 23(10):1729-33. PubMed ID: 8895149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O; Haïm T
    Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights.
    Mahler M; Raijmakers R
    Autoimmun Rev; 2007 Aug; 6(7):432-7. PubMed ID: 17643929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic significance of scleroderma and myositis-associated autoantibodies].
    Genth E; Mierau R
    Z Rheumatol; 1995; 54(1):39-49. PubMed ID: 7725809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Unusual manifestation of scleroderma of the trunk].
    Hackel H; Zillikens D; Lechner W; Burg G
    Hautarzt; 1990 Feb; 41(2):91-3. PubMed ID: 2180858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinuclear antibodies in progressive systemic sclerosis.
    Riboldi P; Asero R; Origgi L; Crespi S; Meroni PL; Sguotti C; Sabbadini MG
    Clin Exp Rheumatol; 1985; 3(3):205-11. PubMed ID: 3902296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome studies in scleroderma with consideration of anticentromere antibody status and assessment of possible in vitro clastogenic activity.
    Powell FC; Schroeter AL; Winkelmann RK; Dewald GW
    Acta Derm Venereol; 1986; 66(5):414-8. PubMed ID: 2431579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunologic findings in progressive scleroderma--diagnostic and nosologic significance].
    Sönnichsen N; Brenke A; Barthelmes H; Albrecht-Nebe H; Diezel W
    Dermatol Monatsschr; 1983 Jun; 169(6):385-93. PubMed ID: 6603989
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen.
    Mahler M; Raijmakers R; Dähnrich C; Blüthner M; Fritzler MJ
    Arthritis Res Ther; 2005; 7(3):R704-13. PubMed ID: 15899056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antinuclear, anti-DNA and anti-lymphocyte antibodies in systemic scleroderma. 62 cases].
    Dourdan P; Labro MT; Bourgeois P; Vinceneux P; Elias I; Kaplan G; Kahn MF
    Rev Rhum Mal Osteoartic; 1983 Jun; 50(7):521-4. PubMed ID: 6604306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical, serological and immunogenetic studies of systemic sclerosis: a French response to the paper of JP Maddison].
    Meyer O
    Rev Rhum Mal Osteoartic; 1991 May; 58(5):371-3. PubMed ID: 1647545
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prolactin levels in patients with systemic scleroderma].
    Alekperov RT; Nasonov EL; Masenko VP; Guseva NG
    Klin Med (Mosk); 1998; 76(4):25-9. PubMed ID: 9613077
    [No Abstract]   [Full Text] [Related]  

  • 17. [The clinical spectrum of patients with anticentromere antibodies].
    Insua Vilariño S; de la Hera Martínez M; Rodríguez-Valverde V; Merino Pérez J; Alonso Valdivieso JL; Ruiz T
    Rev Clin Esp; 1993 Apr; 192(6):260-4. PubMed ID: 8497719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case report of typical scleroderma accompanied with serum abnormalities characteristic of SLE during the course].
    Nishiyama S; Kakihara H; Miyawaki S
    Ryumachi; 1997 Feb; 37(1):24-9. PubMed ID: 9128420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunology and clinical picture of progressive scleroderma].
    Sönnichsen N
    Z Hautkr; 1985 Dec; 60(23):1829-30, 1833-4. PubMed ID: 2936012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating immune complexes in systemic scleroderma.
    Swierczynska Z; Rdultowska H; Blaszczyk M; Jablonska S; Luft S
    Immunol Commun; 1984; 13(5):433-8. PubMed ID: 6335127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.